Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial

Autor: Jing Lu, Christopher Song, Prashant Patel, Christopher Howes, Michael Cleman, Alexandra Lansky, Tayyab Shah, Marianne McCarthy, Irem Nasir, Herb Archer, Elio Ragheb, Jonathan Kluger, Nitu Kashyap, Carlos Paredes, Prakash Kandel, Mustafa Khan, Haocheng Huang, Faheem Ul Haq, Rami Ahmad, Brian Cambi, Gilead Lancaster, Charles Dela Cruz, Helen Parise

Publikováno v: BMJ Open, Vol 13, Iss 2 (2023)

Objective To evaluate the effect of colchicine and high-intensity rosuvastatin in addition to standard of care on the progression of COVID-19 disease in hospitalised patients.Design A pragmatic, open-label, multicentre, randomised controlled trial co

Externí odkaz: https://doaj.org/article/24b5e3ac4e2a403f883faa5073d0c2db

Racial disparities in the SOFA score among patients hospitalized with COVID-19.

Autor: Benjamin Tolchin, Carol Oladele, Deron Galusha, Nitu Kashyap, Mary Showstark, Jennifer Bonito, Michelle C Salazar, Jennifer L Herbst, Steve Martino, Nancy Kim, Katherine A Nash, Max Jordan Nguemeni Tiako, Shireen Roy, Rebeca Vergara Greeno, Karen Jubanyik

Publikováno v: PLoS ONE, Vol 16, Iss 9, p e0257608 (2021)

BackgroundSequential Organ Failure Assessment (SOFA) score predicts probability of in-hospital mortality. Many crisis standards of care suggest the use of SOFA scores to allocate medical resources during the COVID-19 pandemic.Research questionAre SOF

Externí odkaz: https://doaj.org/article/202eb67396744f559ab3d74d98a1d9d0

COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.

Autor: César Caraballo, Megan McCullough, Michael A Fuery, Fouad Chouairi, Craig Keating, Neal G Ravindra, P Elliott Miller, Maricar Malinis, Nitu Kashyap, Allen Hsiao, F Perry Wilson, Jeptha P Curtis, Matthew Grant, Eric J Velazquez, Nihar R Desai, Tariq Ahmad

Publikováno v: PLoS ONE, Vol 15, Iss 9, p e0238829 (2020)

BackgroundPatients with comorbid conditions have a higher risk of mortality with SARS-CoV-2 (COVID-19) infection, but the impact on heart failure patients living near a disease hotspot is unknown. Therefore, we sought to characterize the prevalence a

Externí odkaz: https://doaj.org/article/67767987802e4cebba761bde0cb5ee47

REVeAL-HF

Autor: F. Perry Wilson, Tariq Ahmad, Eric J. Velazquez, Yu Yamamoto, Nihar R. Desai, Allen L. Hsiao, Nitu Kashyap, Aditya Biswas, Michael Simonov, Melissa Martin, Lama Ghazi

Publikováno v: JACC: Heart Failure. 9:409-419

Heart failure (HF) is one of the most common causes of hospitalization in the United States and carries a significant risk of morbidity and mortality. Use of evidence-based interventions may improve outcomes, but their use is encumbered in part by li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b9666b7fb31c457160b468bb38ba96b
https://doi.org/10.1016/j.jchf.2021.03.006

Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin

Autor: Margaret B. Nolan, Thomas M. Piasecki, Stevens S. Smith, Timothy B. Baker, Michael C. Fiore, Robert T. Adsit, Daniel M. Bolt, Karen L. Conner, Steven L. Bernstein, Oliver D. Eng, David Lazuk, Alec Gonzalez, Todd Hayes-Birchler, Douglas E. Jorenby, Heather D'Angelo, Julie A. Kirsch, Brian S. Williams, Sean Kent, Hanna Kim, Stanley A. Lubanski, Menggang Yu, Youmi Suk, Yuxin Cai, Nitu Kashyap, Jomol Mathew, Gabriel McMahan, Betsy Rolland, Hilary A. Tindle, Graham W. Warren, Noor Abu-el-rub, Lawrence C. An, Andrew D. Boyd, Darlene H. Brunzell, Victor A. Carrillo, Li-Shiun Chen, James M. Davis, Vikrant G. Deshmukh, Deepika Dilip, Adam O. Goldstein, Patrick K. Ha, Eduardo Iturrate, Thulasee Jose, Niharika Khanna, Andrea King, Elizabeth Klass, Michelle Lui, Robin J. Mermelstein, Chester Poon, Elisa Tong, Karen M. Wilson, Wendy E. Theobald, Wendy S. Slutske

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 32, iss 1

Background: There is mixed evidence about the relations of current versus past cancer with severe COVID-19 outcomes and how they vary by patient and cancer characteristics. Methods: Electronic health record data of 104,590 adult hospitalized patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80b60305b9defdd7c5c14da615496cd
https://pubmed.ncbi.nlm.nih.gov/36620898